May 27, 2021 7:00am EDT Can-Fite Reports First Quarter 2021 Financial Results & Provides Clinical Update
May 27, 2021 6:00am EDT Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
May 06, 2021 7:00am EDT Can-Fite to Present at Benzinga’s Global Small Cap Conference on May 13, 2021
Apr 29, 2021 7:00am EDT Can-Fite’s Phase III Psoriasis Study Achieves 75% Enrollment; Top Line Results Expected Q4 2021
Apr 20, 2021 7:00am EDT Can-Fite Initiates Preclinical Studies Required by FDA and EMA for the Registration of its Two Lead Drug Candidates
Apr 05, 2021 7:00am EDT Can-Fite: Cannabis Compound Inhibits Liver Cancer Growth in Preclinical Studies
Mar 30, 2021 8:00am EDT Can-Fite: Summary of Existing Out-licensing Deals with Potential Milestone Payments of up to approximately $130 million
Mar 25, 2021 8:29am EDT Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update
Mar 19, 2021 7:00am EDT Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
